Literature DB >> 32748701

Descriptions of Gabapentin Misuse and Associated Behaviors among a Sample of Opioid (Mis)users in South Florida.

Mance E Buttram1, Steven P Kurtz1.   

Abstract

Gabapentin has received increased attention due to a growing number of reports of misuse and diversion. However, significant details about gabapentin misuse are scant. Data are drawn from a mixed-methods study examining gabapentin misuse in South Florida. The sample includes 49 respondents who were age 18 or over and reported past year use of illicit opioids and/or the misuse of prescription opioid medications, as well as, recent (past 90 days) gabapentin misuse. Respondents were female (40.8%), Hispanic (30.6%), Black (16.3%), white (49.0%), and other race/ethnicity (4.1%). Mean age was 37.6. Many respondents (43%) misused gabapentin without ever receiving a prescription and 14% misused prior to being prescribed. Mean frequency of recent misuse was 25.4 days and included a mean of 51.65 pills/doses. Prevalent routes of administration included swallowing (85.7%) and snorting (10.2%). Gabapentin misuse occurred concomitantly with any opioid (44.9%), benzodiazepines (38.8%), alcohol (24.5%), and powder cocaine (24.5), among others. Respondents' descriptions indicate that gabapentin produces feelings reminiscent of alcohol intoxication or opioid-induced euphoria, but for some it produces no noticeable effect or only alleviates pain. Greater understanding of gabapentin misuse, especially associated behaviors and concomitant use is needed to inform prevention and intervention efforts, and to guide policy approaches.

Entities:  

Keywords:  Gabapentin; concomitant use; opioids; qualitative; routes of administration

Mesh:

Substances:

Year:  2020        PMID: 32748701      PMCID: PMC7858688          DOI: 10.1080/02791072.2020.1802087

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  25 in total

1.  Qualitative Descriptive Methods in Health Science Research.

Authors:  Karen Jiggins Colorafi; Bronwynne Evans
Journal:  HERD       Date:  2016-01-19

2.  Gabapentin prescribed during substance abuse treatment: The perspective of treatment providers.

Authors:  Mance E Buttram; Steven P Kurtz; Matthew S Ellis; Theodore J Cicero
Journal:  J Subst Abuse Treat       Date:  2019-07-21

3.  A qualitative analysis of gabapentin misuse and diversion among people who use drugs in Appalachian Kentucky.

Authors:  Rachel Vickers Smith; Elaine M Boland; April M Young; Michelle R Lofwall; Alexa Quiroz; Michele Staton; Jennifer R Havens
Journal:  Psychol Addict Behav       Date:  2017-12-14

4.  Prescription medication misuse among opioid dependent patients seeking inpatient detoxification.

Authors:  Timothy Wilens; Courtney Zulauf; Denece Ryland; Nicholas Carrellas; Isela Catalina-Wellington
Journal:  Am J Addict       Date:  2015-03

5.  Intranasal transmission of hepatitis C virus: virological and clinical evidence.

Authors:  Sagiv Aaron; James M McMahon; Danielle Milano; Leilani Torres; Michael Clatts; Stephanie Tortu; Donna Mildvan; Malgorzata Simm
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

6.  Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers.

Authors:  Colin R W Baird; Pauline Fox; Lesley A Colvin
Journal:  Eur Addict Res       Date:  2013-10-31       Impact factor: 3.015

Review 7.  Gabapentin misuse, abuse and diversion: a systematic review.

Authors:  Rachel V Smith; Jennifer R Havens; Sharon L Walsh
Journal:  Addiction       Date:  2016-03-18       Impact factor: 6.526

8.  Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification.

Authors:  Michael D Stein; Shannon R Kenney; Bradley J Anderson; Micah T Conti; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2019-12-13

9.  Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance.

Authors:  Alyssa M Peckham; Maria J Ananickal; David A Sclar
Journal:  Risk Manag Healthc Policy       Date:  2018-08-17

10.  Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.

Authors:  Tara Gomes; David N Juurlink; Tony Antoniou; Muhammad M Mamdani; J Michael Paterson; Wim van den Brink
Journal:  PLoS Med       Date:  2017-10-03       Impact factor: 11.069

View more
  2 in total

1.  Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.

Authors:  Elizabeth A Ibiloye; Jamie C Barner; Kenneth A Lawson; Karen L Rascati; Kirk E Evoy; Alyssa M Peckham
Journal:  Clin Drug Investig       Date:  2021-02-12       Impact factor: 2.859

2.  Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.

Authors:  Kirk E Evoy; Sarvnaz Sadrameli; Jillian Contreras; Jordan R Covvey; Alyssa M Peckham; Megan D Morrison
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.